RSRC2 and pancreatic ductal adenocarcinoma: Later research found that the expression level of RSRC2 in pancreatic ductal carcinoma was significantly lower than that in normal pancreatic tissue, and it was negatively correlated with the clinical stage of pancreatic ductal carcinoma [6].